101 related articles for article (PubMed ID: 20182391)
1. Blockade of delta-like ligand 4 signaling inhibits both growth and angiogenesis of pancreatic cancer.
Oishi H; Sunamura M; Egawa S; Motoi F; Unno M; Furukawa T; Habib NA; Yagita H
Pancreas; 2010 Aug; 39(6):897-903. PubMed ID: 20182391
[TBL] [Abstract][Full Text] [Related]
2. Delta-like 4 Notch ligand regulates tumor angiogenesis, improves tumor vascular function, and promotes tumor growth in vivo.
Li JL; Sainson RC; Shi W; Leek R; Harrington LS; Preusser M; Biswas S; Turley H; Heikamp E; Hainfellner JA; Harris AL
Cancer Res; 2007 Dec; 67(23):11244-53. PubMed ID: 18056450
[TBL] [Abstract][Full Text] [Related]
3. Dll4 Blockade in Stromal Cells Mediates Antitumor Effects in Preclinical Models of Ovarian Cancer.
Kuhnert F; Chen G; Coetzee S; Thambi N; Hickey C; Shan J; Kovalenko P; Noguera-Troise I; Smith E; Fairhurst J; Andreev J; Kirshner JR; Papadopoulos N; Thurston G
Cancer Res; 2015 Oct; 75(19):4086-96. PubMed ID: 26377940
[TBL] [Abstract][Full Text] [Related]
4. [Influence of Delta-like ligand 4/Notch signal transduction pathway upon the biological behavior of human umbilical vein endothelial cells].
Chen L; Lü W; Wei B; Wang N; Li T
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3106-10. PubMed ID: 20193271
[TBL] [Abstract][Full Text] [Related]
5. DLL4-Notch signaling mediates tumor resistance to anti-VEGF therapy in vivo.
Li JL; Sainson RC; Oon CE; Turley H; Leek R; Sheldon H; Bridges E; Shi W; Snell C; Bowden ET; Wu H; Chowdhury PS; Russell AJ; Montgomery CP; Poulsom R; Harris AL
Cancer Res; 2011 Sep; 71(18):6073-83. PubMed ID: 21803743
[TBL] [Abstract][Full Text] [Related]
6. Roles of nitric oxide synthase inhibition and vascular endothelial growth factor receptor-2 inhibition on vascular morphology and function in an in vivo model of pancreatic cancer.
Camp ER; Yang A; Liu W; Fan F; Somcio R; Hicklin DJ; Ellis LM
Clin Cancer Res; 2006 Apr; 12(8):2628-33. PubMed ID: 16638876
[TBL] [Abstract][Full Text] [Related]
7. A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin.
Kou G; Shi J; Chen L; Zhang D; Hou S; Zhao L; Fang C; Zheng L; Zhang X; Liang P; Zhang X; Li B; Guo Y
Cancer Lett; 2010 Dec; 299(2):130-6. PubMed ID: 20826049
[TBL] [Abstract][Full Text] [Related]
8. Delta-like 4/Notch signaling and its therapeutic implications.
Yan M; Plowman GD
Clin Cancer Res; 2007 Dec; 13(24):7243-6. PubMed ID: 18094402
[TBL] [Abstract][Full Text] [Related]
9. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
Wang Z; Chakravarty G; Kim S; Yazici YD; Younes MN; Jasser SA; Santillan AA; Bucana CD; El-Naggar AK; Myers JN
Clin Cancer Res; 2006 Aug; 12(15):4755-65. PubMed ID: 16899627
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Dll4 signalling inhibits tumour growth by deregulating angiogenesis.
Ridgway J; Zhang G; Wu Y; Stawicki S; Liang WC; Chanthery Y; Kowalski J; Watts RJ; Callahan C; Kasman I; Singh M; Chien M; Tan C; Hongo JA; de Sauvage F; Plowman G; Yan M
Nature; 2006 Dec; 444(7122):1083-7. PubMed ID: 17183323
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
[TBL] [Abstract][Full Text] [Related]
12. Notch signaling from tumor cells: a new mechanism of angiogenesis.
Li JL; Harris AL
Cancer Cell; 2005 Jul; 8(1):1-3. PubMed ID: 16023591
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic efficacy of a DNA vaccine targeting the endothelial tip cell antigen delta-like ligand 4 in mammary carcinoma.
Haller BK; Bråve A; Wallgard E; Roswall P; Sunkari VG; Mattson U; Hallengärd D; Catrina SB; Hellström M; Pietras K
Oncogene; 2010 Jul; 29(30):4276-86. PubMed ID: 20498640
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the therapeutic efficacy of a VEGFR2-blocking antibody using sodium-iodide symporter molecular imaging in a tumor xenograft model.
Cheong SJ; Lee CM; Kim EM; Uhm TB; Jeong HJ; Kim DW; Lim ST; Sohn MH
Nucl Med Biol; 2011 Jan; 38(1):93-101. PubMed ID: 21220132
[TBL] [Abstract][Full Text] [Related]
15. Nuclear and membrane expression of the angiogenesis regulator delta-like ligand 4 (DLL4) in normal and malignant human tissues.
Martinez JC; Müller MM; Turley H; Steers G; Choteau L; Li JL; Sainson R; Harris AL; Pezzella F; Gatter KC
Histopathology; 2009 Apr; 54(5):598-606. PubMed ID: 19413639
[TBL] [Abstract][Full Text] [Related]
16. A neutralizing anti-fibroblast growth factor (FGF) 8 monoclonal antibody shows anti-tumor activity against FGF8b-expressing LNCaP xenografts in androgen-dependent and -independent conditions.
Maruyama-Takahashi K; Shimada N; Imada T; Maekawa-Tokuda Y; Ishii T; Ouchi J; Kusaka H; Miyaji H; Akinaga S; Tanaka A; Shitara K
Prostate; 2008 May; 68(6):640-50. PubMed ID: 18213631
[TBL] [Abstract][Full Text] [Related]
17. Blockade of Dll4 inhibits tumour growth by promoting non-productive angiogenesis.
Noguera-Troise I; Daly C; Papadopoulos NJ; Coetzee S; Boland P; Gale NW; Lin HC; Yancopoulos GD; Thurston G
Nature; 2006 Dec; 444(7122):1032-7. PubMed ID: 17183313
[TBL] [Abstract][Full Text] [Related]
18. Plasminogen activator inhibitor-1 (PAI-1) gene transfection inhibits the liver metastasis of pancreatic cancer by preventing angiogenesis.
Inoue M; Sawada T; Uchima Y; Kimura K; Nishihara T; Tanaka H; Yashiro M; Yamada N; Ohira M; Hirakawa K
Oncol Rep; 2005 Dec; 14(6):1445-51. PubMed ID: 16273237
[TBL] [Abstract][Full Text] [Related]
19. New pathways and mechanisms regulating and responding to Delta-like ligand 4-Notch signalling in tumour angiogenesis.
Oon CE; Harris AL
Biochem Soc Trans; 2011 Dec; 39(6):1612-8. PubMed ID: 22103496
[TBL] [Abstract][Full Text] [Related]
20. Delta-like ligand 4 (Dll4) is induced by VEGF as a negative regulator of angiogenic sprouting.
Lobov IB; Renard RA; Papadopoulos N; Gale NW; Thurston G; Yancopoulos GD; Wiegand SJ
Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3219-24. PubMed ID: 17296940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
